Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001641172-25-024511
Filing Date
2025-08-15
Accepted
2025-08-15 21:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3522
  Complete submission text file 0001641172-25-024511.txt   5283
Mailing Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065
Business Address 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Subject) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36593 | Film No.: 251226115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PRINCES HOUSE 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address PRINCES HOUSE 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 207 534 1500
Abingworth Bioventures VII LP (Reporting) CIK: 0001688313 (see all company filings)

EIN.: 931331173 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144